Table 2.
Use of vitamin D and probiotics supplements by TEDDY participants during the first two years of life.
| Single Supplements,
n(%)a
|
MVMs, n(%)a,b
|
MVMs, n(%)a,c
|
No Supplement Use |
||||
|---|---|---|---|---|---|---|---|
| Vitamin D | Probiotics | Vitamin D+ | Vitamin D− | Probiotics+ | Probiotics− | ||
| United States (n=3725) | 291 (7.8) | 208 (5.6) | 1824 (49.0) | 394 (10.6) | 26 (0.7) | 2192 (58.9) | 1533 (41.1) |
| Finland (n=1832) | 1822 (99.4) | 1081 (59.0) | 326 (17.8) | 96 (5.2) | 64 (3.5) | 358 (19.6) | 7 (0.4) |
| Germany (n=594) | 296 (49.8) | 39 (6.6) | 485 (81.7) | 12 (2.0) | 4 (0.7) | 493 (82.7) | 11 (1.9) |
| Sweden (n=2525) | 903 (35.8) | 369 (14.6) | 2149 (85.1) | 40 (1.6) | 1 (<0.1) | 2188 (86.7) | 8 (0.3) |
| Total (n=8674) | 3312 (38.1) | 1697 (19.6) | 4784 (55.2) | 542 (6.2) | 95 (1.1) | 5231 (60.3) | 1557 (18.0) |
TEDDY, The Environmental Determinants of Diabetes in the Young; MVMs, multivitamin and mineral supplements
a
n= number of reported products. % = user percentage within a country.
b
MVMs are separated into vitamin D-containing products (Vitamin D+) and vitamin D-free products (Vitamin D−).
c
MVMs are separated into probiotics-containing products (Probiotics +) and probiotics-free products (Probiotics−).